InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Allen Andrew R, 董事长兼首席执行官. Officer active across 3 companies, notably Epizyme, Inc.. Cumulatively, 8 filings have been logged. Activity tracked since 11 June 2021. The latest transaction was disclosed on 24 June 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Allen Andrew R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
325,000 股0Common StockSEC:0001415889-24-018275:0
47,873 股0Common StockSEC:0001415889-24-013657:0
105,000 股0Common StockSEC:0001415889-24-002702:0
738,550 股0Common StockSEC:0001567619-23-001941:0
1,650 股@ US$55.00100.0% 占其流量Common StockSEC:0001209191-22-040258:0
70,000 股0Common StockSEC:0001567619-22-008708:0
48,200 股0Common StockSEC:0001567619-21-020853:0
8,060 股0Common Stock, par value $0.0001SEC:0000899243-21-023872:0
8 条申报中的 8 条
About Allen Andrew R
Allen Andrew R is the President and CEO of Epizyme, Inc., Gritstone bio, Inc., and Sierra Oncology, Inc. He leads the operations and strategy of these companies, ensuring their growth and success. His leadership and vision are essential for achieving the objectives of each company. Andrew is committed to promoting innovation and excellence in the biopharmaceutical sector.
